Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pasadena Research Labs

Executive Summary

Former Lyphomed Chief Operating Officer Floyd Benjamin acquires an interest in the San Clemente, Calif.-based firm and assumes the title of partner of scientific affairs, responsible for science and regulatory issues, the company reports. Pasadena Research Labs describes itself as a provider of "specialty injectable drugs to hospitals and physicians, with an emphasis on sourcing hard-to-find products." Benjamin most recently was president and CEO of the Irvine, Calif.-based biotech firm Neocrine.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS023568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel